Renaissance Technologies’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.6M | Buy |
+196,918
| New | +$16.7M | 0.02% | 827 |
|
|
2025
Q4 | – | Sell |
-243,918
| Closed | -$14M | – | 3426 |
|
|
2025
Q3 | $14M | Buy |
243,918
+138,500
| +131% | +$7.98M | 0.02% | 908 |
|
|
2025
Q2 | $6.22M | Sell |
105,418
-71,500
| -40% | -$4.62M | 0.01% | 1382 |
|
|
2025
Q1 | $13M | Buy |
+176,918
| New | +$14.6M | 0.02% | 869 |
|
|
2023
Q4 | – | Sell |
-158,518
| Closed | -$7.87M | – | 3861 |
|
|
2023
Q3 | $7.87M | Buy |
+158,518
| New | +$8.86M | 0.01% | 1060 |
|
|
2022
Q3 | – | Sell |
-54,700
| Closed | -$3.07M | – | 4159 |
|
|
2022
Q2 | $3.07M | Sell |
54,700
-10,100
| -16% | -$664K | ﹤0.01% | 1894 |
|
|
2022
Q1 | $4.78M | Buy |
64,800
+17,700
| +38% | +$1.23M | 0.01% | 1622 |
|
|
2021
Q4 | $3.4M | Sell |
47,100
-133,546
| -74% | -$9.69M | ﹤0.01% | 1778 |
|
|
2021
Q3 | $13.8M | Buy |
180,646
+37,546
| +26% | +$3.01M | 0.02% | 853 |
|
|
2021
Q2 | $11.1M | Sell |
143,100
-25,600
| -15% | -$1.82M | 0.01% | 1102 |
|
|
2021
Q1 | $10.4M | Buy |
168,700
+39,200
| +30% | +$2.48M | 0.01% | 1166 |
|
|
2020
Q4 | $8.45M | Sell |
129,500
-14,014
| -10% | -$806K | 0.01% | 1274 |
|
|
2020
Q3 | $7.11M | Sell |
143,514
-566,800
| -80% | -$29.2M | 0.01% | 1359 |
|
|
2020
Q2 | $33.9M | Sell |
710,314
-634,400
| -47% | -$30.6M | 0.03% | 562 |
|
|
2020
Q1 | $57.2M | Buy |
1,344,714
+266,700
| +25% | +$13.2M | 0.06% | 350 |
|
|
2019
Q4 | $63.5M | Sell |
1,078,014
-167,386
| -13% | -$9.09M | 0.05% | 428 |
|
|
2019
Q3 | $63.7M | Sell |
1,245,400
-19,200
| -2% | -$914K | 0.05% | 416 |
|
|
2019
Q2 | $53.5M | Sell |
1,264,600
-95,200
| -7% | -$4.13M | 0.05% | 464 |
|
|
2019
Q1 | $67.2M | Buy |
1,359,800
+137,400
| +11% | +$6.22M | 0.06% | 389 |
|
|
2018
Q4 | $52.9M | Buy |
1,222,400
+331,965
| +37% | +$16.6M | 0.06% | 401 |
|
|
2018
Q3 | $50.5M | Buy |
890,435
+35,535
| +4% | +$1.87M | 0.05% | 428 |
|
|
2018
Q2 | $43.1M | Buy |
854,900
+351,100
| +70% | +$18.3M | 0.05% | 504 |
|
|
2018
Q1 | $25.1M | Buy |
503,800
+82,600
| +20% | +$3.88M | 0.03% | 801 |
|
|
2017
Q4 | $17.3M | Sell |
421,200
-258,100
| -38% | -$9.04M | 0.02% | 1043 |
|
|
2017
Q3 | $20.2M | Buy |
679,300
+608,900
| +865% | +$18.6M | 0.02% | 894 |
|
|
2017
Q2 | $2.33M | Buy |
+70,400
| New | +$2.21M | ﹤0.01% | 2171 |
|
|
2016
Q3 | – | Sell |
-104,700
| Closed | -$2.5M | – | 3387 |
|
|
2016
Q2 | $2.5M | Sell |
104,700
-242,000
| -70% | -$5.8M | ﹤0.01% | 2072 |
|
|
2016
Q1 | $8.23M | Buy |
+346,700
| New | +$8.48M | 0.02% | 1271 |
|
|
2015
Q4 | – | Sell |
-143,945
| Closed | -$2.97M | – | 3323 |
|
|
2015
Q3 | $2.97M | Buy |
+143,945
| New | +$3.65M | 0.01% | 1736 |
|
|
2015
Q2 | – | Sell |
-98,300
| Closed | -$2.48M | – | 3276 |
|
|
2015
Q1 | $2.48M | Sell |
98,300
-151,800
| -61% | -$3.7M | 0.01% | 1813 |
|
|
2014
Q4 | $5.95M | Sell |
250,100
-602,400
| -71% | -$13.3M | 0.01% | 1174 |
|
|
2014
Q3 | $16.8M | Buy |
852,500
+66,100
| +8% | +$1.36M | 0.05% | 518 |
|
|
2014
Q2 | $18.8M | Buy |
786,400
+605,287
| +334% | +$14.6M | 0.04% | 509 |
|
|
2014
Q1 | $4.82M | Sell |
181,113
-92,487
| -34% | -$2.2M | 0.01% | 1274 |
|
|
2013
Q4 | $5.52M | Buy |
+273,600
| New | +$5.08M | 0.01% | 1128 |
|
Other funds holding GMED
JT
SC
Renaissance Technologies's GMED Position: Q2 2026 in Review
Renaissance Technologies opened a new position in Globus Medical (GMED) in Q2 2026: 196,918 shares worth $15.6M. The stake represents 0.02% of the portfolio and ranks #827 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in GMED as recently as Q3 2025.
Renaissance Technologies first reported a position in GMED in Q4 2013 and has held it in 35 quarters since. The position peaked at $67.2M in Q1 2019. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Renaissance Technologies held 196,918 shares of Globus Medical worth $15.6M as of Q2 2026.
- Globus Medical was a new Renaissance Technologies position in Q2 2026.
- Globus Medical made up 0.02% of Renaissance Technologies's portfolio in Q2 2026, its #827 holding.
- Renaissance Technologies first reported a position in Globus Medical in Q4 2013 and has held it in 35 quarters since.
- Renaissance Technologies's Globus Medical position peaked at $67.2M in Q1 2019.
- 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.